CAS:761439-42-3

761439-42-3 Technical Data:

Price and Availability of Cas No:761439-42-3

Cas : 761439-42-3 M.Wt: 614.2017
Cas : 761439-42-3 Formula: C30H40ClN7O3S
Cas : 761439-42-3 Purity: >98 %
Cas : 761439-42-3 Storage: at 20℃ 2 years
Cas : 761439-42-3 Solubility: 10 mM in DMSO
Cas : 761439-42-3 Name: NVP-TAE 684

USD
5mg/$80	In-stock
10mg/$120	In-stock
50mg/$320	In-stock
100mg/$450	In-stock
1g	Get quote
5g	Get quote
>10g	Get quote
We match the lowest price on market.
We offer a substantial discount on larger orders,please inquire via sales@chemexpress.cn or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Online Inquiry

Inquiry Online

Hide

Salutation:		Country:
Customer:		Company Name:
Email:		Requested quantity:
Remarks:

761439-42-3 Data Sheet:

Introduction of 761439-42-3 :
NVP-TAE 684 is a highly potent and selective ALK inhibitor, which blocks the growth of ALCL-derived and ALK-dependent cell lines with IC₅₀ values between 2 and 10 nM. In Vitro: TAE684 inhibits the proliferation of Ba/F3 NPM-ALK cells with an ICsub>50 of 3 nM, without affecting the survival of parental Ba/F3 cells at concentrations up to 1 μM. TAE684 inhibits STAT3 and STAT5 phosphorylation in a dose-dependent manner in both Ba/F3 NPM-ALK and Karpas-299 cells. TAE684 induces apoptosis and G1 phase arrest in NPM-ALK-expressing Ba/F3 cells and ALCL patient cell lines^[1]. NVP-TAE684 markedly reduces cell survival in both sensitive H3122 and H3122 CR cells, but has little to no effect on the viability of other, non-ALK-dependent cancer cell lines. NVP-TAE684 treatment of H3122 CR cells suppresses phosphorylation of ALK, AKT, and ERK and induces marked apoptosis. TAE684 potently suppresses the survival of Ba/F3 cells expressing the EML4-ALK L1196M mutant^[2]. Neurite outgrowth induced by expression of the mALKR1279Q mutant is completely inhibited at 30 nM NVP-TAE684, which is comparable with the response seen with activated wt mALK^[3]. In Vivo: NVP-TAE684 suppresses lymphomagenesis in two independent models of ALK-positive ALCL and induces regression of established Karpas-299 lymphomas. TAE684 displays appreciable bioavailability and half-life in vivo. TAE684 (1, 3, and 10 mg/kg. p.o.) significantly delays in lymphoma development and shows 100- to 1,000-fold reduction in luminescence signal. The TAE684- (10 mg/kg) treated group appeares healthy and does not display any signs of compound- or disease-related toxicity^[1].?

References on 761439-42-3 :

Insert title here

Products are for research use only. Not for human use. We do not sell to patients. Copyright © 2009 Haoyuan Chemexpress All Rights Reserved
ADDRESS: 6/F, No. 2 Building, No. 720,Cailun Road, Shanghai, P.R.China
TEL: 86-21-58998590 FAX: 86-21-53700326, 86-21-58998590 E-mail： sales@chemexpress.cn